BamSEC and AlphaSense Join Forces
Learn More

Brainstorm Cell Therapeutics Inc.

NASDAQ: BCLI    
Share price (12/20/24): $2.28    
Market cap (12/20/24): $13.0 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.10
from 8-K 1 page Brainstorm Cell Therapeutics Inc. Amendment No. 4 to 2014 Global Share Option Plan
12/34/56
EX-10.5
from 8-K 1 page Brainstorm Cell Therapeutics Inc. Amendment No. 4 to 2014 Stock Incentive Plan
12/34/56
EX-10.10
from 10-Q 7 pages Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan Award Agreement for Restricted Stock Units Granted Under Section 102(b)(2) of the Israeli Income Tax Ordinance to Employees, Officers or Directors as 102 Capital Gains Track Grant
12/34/56
EX-10.9
from 10-Q 7 pages Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan Award Agreement for Restricted Stock Units Granted Under Section 102(b)(2) of the Israeli Income Tax Ordinance to Employees, Officers or Directors as 102 Capital Gains Track Grant
12/34/56
EX-10.8
from 10-Q 4 pages Brainstorm Cell Therapeutics Inc. Restricted Stock Agreement Granted Under 2014 Stock Incentive Plan
12/34/56
EX-10.7
from 10-Q 7 pages Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan Award Agreement for Restricted Stock Units Granted Under Section 102(b)(2) of the Israeli Income Tax Ordinance to Employees, Officers or Directors as 102 Capital Gains Track Grant
12/34/56
EX-10.2
from 10-Q 8 pages April 16, 2024 Personal and Confidential Stacy Lindborg Re:separation Agreement Dear Stacy: This Letter Confirms Your Separation From Employment With Brainstorm Cell Therapeutics (The “Company”) Effective as of May 9, 2024 (The “Separation Date”). This Letter Also Proposes an Agreement Between You and the Company (The “Agreement”). First, a Few Formalities. Regardless of Whether You Sign the Agreement Below: ● the Company Shall Pay You Salary and Unpaid and Properly Documented Expenses Accrued to You Through the Separation Date
12/34/56
EX-10.1
from 10-Q 25 pages June 19, 2024 Dr. Hartoun Hartounian Re: Employment Offer Dear Dr. Hartounian I Am Pleased to Offer You Employment With Brainstorm Cell Therapeutics Inc., a Delaware Corporation (The “Company”). the Initial Terms of Your Employment, Should You Accept This Offer, Are Set Forth Below (The “Agreement”)
12/34/56
EX-10.3
from 8-K 2 pages Holder of Warrants to Purchase Common Stock Issued on July 19, 2023 Re: Amendment to Existing Warrants Dear Holder
12/34/56
EX-10.2
from 8-K 13 pages Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.73
from 10-K ~1 page Amendment to Employment Agreement
12/34/56
EX-10.72
from 10-K ~1 page Amendment to Employment Agreement
12/34/56
EX-10.71
from 10-K ~1 page Amendment to Employment Agreement
12/34/56
EX-10.70
from 10-K ~1 page Amendment to Employment Agreement
12/34/56
EX-10.69
from 10-K 6 pages Personal Employment Agreement
12/34/56
EX-10.2
from 8-K 13 pages Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 37 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 5 pages Separation Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amendment No. 3 to Offer Letter Agreement
12/34/56